4//SEC Filing
Hillan Kenneth J. 4
Accession 0001209191-22-014134
CIK 0001001233other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:09 PM ET
Size
8.4 KB
Accession
0001209191-22-014134
Insider Transaction Report
Form 4
Hillan Kenneth
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-02-25+25,000→ 25,000 totalExercise: $5.90Exp: 2032-02-24→ Common Stock (25,000 underlying) - Award
Common Stock
2022-02-25+12,500→ 35,700 total
Footnotes (3)
- [F1]Represents shares of common stock issuable upon settlement of a restricted stock unit ("RSU") grant that will fully vest on the first anniversary of the grant date, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP")) through such date and subject to acceleration as provided in the 2018 EIP.
- [F2]Includes 10,000 shares subject to the Reporting Person's September 9, 2020 RSU grant that will vest in two remaining annual installments of 5,000 shares on each of September 9, 2022 and 2023, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
- [F3]The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001600359
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:09 PM ET
- Size
- 8.4 KB